Home › Funds › Rock Springs Capital Management LP › DYN

Rock Springs Capital Management LP position in DYN

DYNE THERAPEUTICS INC · Health Care

Rock Springs Capital Management LP reported holding 891,869 shares of DYN (DYNE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$14.4M, representing 0.78% of its reported portfolio and ranking #42 among its reported holdings. Rock Springs Capital Management LP has disclosed DYN holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)891.87K sh
Reported value held$14.37M
Portfolio Weight0.78%
First reportedQ1 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Rock Springs Capital Management LP's DYN position evolved

Rock Springs Capital Management LP first disclosed a stake in DYN in Q1 2024 at 451,824 shares (US$12.8M). The position peaked in Q2 2026 at 942,154 shares, worth US$20.9M. Across 11 filings, Rock Springs Capital Management LP increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 891,869 shares valued at US$14.4M — a reduction of -50,285 shares quarter over quarter.. Notable position changes include a 42% increase in Q3 2025 (shares rose 55% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 451.82K $12.83M New
Q2 2024 461.03K $16.27M Add
Q3 2024 461.03K $16.56M Hold
Q4 2024 474.53K $11.18M Add
Q1 2025 524.50K $5.49M Add
Q2 2025 581.00K $5.53M Add
Q3 2025 824.06K $10.42M Add
Q4 2025 912.96K $17.86M Add
Q1 2026 972.20K $17.63M Add
Q2 2026 942.15K $20.93M Reduce
Q3 2026 891.87K $14.37M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DYN and 13F data

DYN (DYNE THERAPEUTICS INC) is a Health Care company. 36 other funds we track also report a position in DYN — the largest reported positions include Vestal Point Capital, LP (US$75.0M), TCG Crossover Management, LLC (US$74.3M), ORBIMED ADVISORS LLC (US$71.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DYN

All DYN fund holders →

FAQ

How long has Rock Springs Capital Management LP held DYN?

Rock Springs Capital Management LP has disclosed DYN holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Rock Springs Capital Management LP's current position in DYN?

As of Q3 2026, Rock Springs Capital Management LP holds 891.87K shares of DYN (DYNE THERAPEUTICS INC), valued at $14.37M, representing 0.78% of its reported portfolio and ranking #42.

Has Rock Springs Capital Management LP been buying or selling DYN?

In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP reduced its position in DYN. The position peaked in Q2 2026 at 942.15K shares.

Which other funds hold DYN?

Other major institutional holders of DYN include Vestal Point Capital, LP, TCG Crossover Management, LLC, ORBIMED ADVISORS LLC, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.